News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

BY HELEN W. BOUCHER, MD, FACP, FIDSA

Advertisement

Articles by BY HELEN W. BOUCHER, MD, FACP, FIDSA

Have we made progress in the 10 X' 20 Initative?

ByBY HELEN W. BOUCHER, MD, FACP, FIDSA
April 9th 2020

IDSA reached its goal, but nobody’s buying. Can the drowning antimicrobial pipeline be saved?

Advertisement

Latest Updated Articles

  • Have we made progress in the 10 X' 20 Initative?
    Have we made progress in the 10 X' 20 Initative?

    Published: April 9th 2020 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Zoliflodacin Emerges as a First-in-Class Oral Option Against Drug-Resistant Gonorrhea

2

Top Infectious Disease News Stories Week of December 6 - December 12

3

FDA Approves Zoliflodacin for Uncomplicated Urogenital Gonorrhea

4

"Complicating the Decision-Making" for the Universal Birth Dose of the Hepatitis B Vaccine

5

A Pediatrician’s Perspective on the Latest ACIP Hepatitis B Vaccine Recommendations

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us